MHRA seizures show why medicines wholesale businesses need strong supplier checks, GDP controls and compliance route reviews before moving forward.
Let’s route your enquiry to the right place.
Your information will only be used by us in line with our Privacy Notice.
Let’s route your enquiry to the right place.
Your information will only be used by us in line with our Privacy Notice.
MHRA seizures show why medicines wholesale businesses need strong supplier checks, GDP controls and compliance route reviews before moving forward.
New UK supply chain warnings show why medicines wholesalers need early warning systems, GDP controls and clear escalation processes.
MHRA’s latest licence update shows ongoing medicines wholesale activity. Learn why WDA(H) readiness, GDP systems and RP oversight matter before market entry.
MHRA performance updates show faster medicines access in the UK. Learn why GDP readiness, WDA(H) planning and distribution controls matter.
Recent MHRA updates show why medicine wholesalers need strong labelling, PIL, documentation and GDP quality controls.
New DHSC medicine supply guidance shows why wholesalers need clear GDP escalation, documentation and communication processes.
An MHRA illegal medicines case shows why storage, packaging, distribution routes, GDP controls and WDA(H) readiness matter.
A recent MHRA recall shows why medicines wholesalers need strong storage, transport, quarantine and GDP quality controls.
An MHRA fake Mounjaro warning shows why wholesalers need strong product verification, supplier checks and GDP quality oversight.
A new MHRA safety update shows why medicine wholesalers need strong product information controls, GDP quality systems and RP oversight.
© 2026 TPMG Group Ltd. All rights reserved. TPMG Group Ltd is the commercial and operating hub within the wider TPMG Group. Company number: 14618789. Registered office: Cardinal Point, Park Road, Rickmansworth, WD3 1RE.